Neurocrine Biosciences (NBIX) Tops Q4 EPS by 22c, Guides FY13 Below Street

February 8, 2013 7:09 AM

Neurocrine Biosciences, Inc. (NASDAQ: NBIX) reported Q4 EPS of $0.14, $0.22 better than ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found